login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
AMPHASTAR PHARMACEUTICALS IN (AMPH) Stock News
USA
-
Nasdaq
- NASDAQ:AMPH -
US03209R1032
-
Common Stock
26.77
USD
-0.38 (-1.4%)
Last: 12/5/2025, 8:03:00 PM
26
USD
-0.77 (-2.88%)
After Hours:
12/5/2025, 8:03:00 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
AMPH Latest News, Press Relases and Analysis
All
Press Releases
2 days ago - By: Zacks Investment Research
- Mentions:
PFE
CRMD
Can DefenCath Continue to Aid CorMedix's Long-Term Growth Ahead?
9 days ago - By: The Motley Fool
Amphastar (AMPH) Q3 2025 Earnings Call Transcript
13 days ago - By: ACCESS Newswire
Amphastar Pharmaceuticals to Present at the 37th Annual Piper Sandler Healthcare Conference
a month ago - By: Benzinga
The Analyst Verdict: Amphastar Pharma In The Eyes Of 4 Experts
a month ago - By: ACCESS Newswire
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2025
a month ago - By: Benzinga
- Mentions:
STVN
PODD
AMRK
SOLV
...
Earnings Scheduled For November 6, 2025
25 days ago - By: ACCESS Newswire
Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
a month ago - By: Zacks Investment Research
Here's What Key Metrics Tell Us About Amphastar (AMPH) Q3 Earnings
a month ago - By: Zacks Investment Research
- Mentions:
CVAC
Amphastar Pharmaceuticals (AMPH) Q3 Earnings and Revenues Top Estimates
a month ago - By: Zacks Investment Research
- Mentions:
PSNL
Personalis (PSNL) Reports Q3 Loss, Tops Revenue Estimates
a month ago - By: Zacks Investment Research
- Mentions:
SUPN
Analysts Estimate Amphastar Pharmaceuticals (AMPH) to Report a Decline in Earnings: What to Look Out for
a month ago - By: ACCESS Newswire
Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6th, 2025
2 months ago - By: Zacks Investment Research
- Mentions:
PFE
CRMD
How Will DefenCath Aid CRMD's Top Line in the Upcoming Q3 Results?
3 months ago - By: Zacks Investment Research
- Mentions:
PFE
CRMD
CorMedix Rallies 60% YTD: Is This an Indication to Buy the Stock?
Please enable JavaScript to continue using this application.